- Home
- OCTO vs OGEN Comparison
OCTO vs OGEN Comparison
Compare OCTO & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCTO
- OGEN
- Stock Information
- Founded
- OCTO 1966
- OGEN 1996
- Country
- OCTO United States
- OGEN United States
- Employees
- OCTO N/A
- OGEN N/A
- Industry
- OCTO
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- OCTO
- OGEN Health Care
- Exchange
- OCTO Nasdaq
- OGEN Nasdaq
- Market Cap
- OCTO 4.4M
- OGEN 4.5M
- IPO Year
- OCTO N/A
- OGEN N/A
- Fundamental
- Price
- OCTO $1.51
- OGEN $0.34
- Analyst Decision
- OCTO
- OGEN
- Analyst Count
- OCTO 0
- OGEN 0
- Target Price
- OCTO N/A
- OGEN N/A
- AVG Volume (30 Days)
- OCTO 29.1K
- OGEN 269.0K
- Earning Date
- OCTO 11-14-2024
- OGEN 11-13-2024
- Dividend Yield
- OCTO N/A
- OGEN N/A
- EPS Growth
- OCTO N/A
- OGEN N/A
- EPS
- OCTO N/A
- OGEN N/A
- Revenue
- OCTO $39,835,256.00
- OGEN N/A
- Revenue This Year
- OCTO N/A
- OGEN N/A
- Revenue Next Year
- OCTO N/A
- OGEN N/A
- P/E Ratio
- OCTO N/A
- OGEN N/A
- Revenue Growth
- OCTO N/A
- OGEN N/A
- 52 Week Low
- OCTO $1.26
- OGEN $0.25
- 52 Week High
- OCTO $4.86
- OGEN $7.74
- Technical
- Relative Strength Index (RSI)
- OCTO 35.84
- OGEN 49.33
- Support Level
- OCTO $1.53
- OGEN $0.32
- Resistance Level
- OCTO $1.70
- OGEN $0.38
- Average True Range (ATR)
- OCTO 0.10
- OGEN 0.03
- MACD
- OCTO -0.01
- OGEN 0.00
- Stochastic Oscillator
- OCTO 7.56
- OGEN 38.89
About OCTO Eightco Holdings Inc.
Eightco Holdings Inc operates in three main businesses: Forever 8 Inventory Cash Flow Solution, Web3 Business, and Packaging Business. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Web3 Business but has no intention of continuing this business at this time. The Packaging Business manufactures and sells custom packaging for a wide variety of products and helps customers generate brand awareness and promote brand image through packaging. The Company's two reportable segments were the Inventory Management Solutions segment and the Corrugated segment. Key revenue is generated from Inventory Management Solutions segment.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.